Navigation Links
ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis
Date:12/8/2008

MINNEAPOLIS, Dec. 8 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced it has received FDA clearance for the marketing of the ATS 3f(R) Aortic Bioprosthesis that includes a new sewing tab material supplier and an improved valve holder accessory device.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO)

While the ATS 3f Aortic Bioprosthesis PMA was approved on October 30, 2008, as previously indicated, a full commercial launch would commence in the first quarter of 2009 once these milestones were achieved. ATS Medical has achieved these milestones and is on track with the previous guidance. The ATS 3f Aortic Bioprosthesis is the Company's first entry into the $400-plus million U.S. tissue valve market.

"The FDA clearance was necessary for ATS Medical to commence a full commercial launch of our first tissue valve in the US. We are excited to achieve these important milestones for the Company," said Michael Dale, President and Chief Executive Officer of ATS Medical. "The tissue valve market presents the largest market opportunity for our Company and will importantly provide ATS Medical the leverage it needs to sustain high growth and enhanced profitability in the future."

Based on the precept that 'Form Follows Function', the ATS 3f Aortic Bioprosthesis is a revolutionary next generation stentless pericardial aortic tissue valve that is unlike any other valve. The tubular design of the ATS 3f Aortic Bioprosthesis maintains the continuity of the annulus and the sino tubular junction. No other valve mimics the native valve in this manner. By maintaining this continuity, the ATS 3f Aortic Bioprosthes
'/>"/>

SOURCE ATS Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. China Sky One Medical, Inc. Interviewed in The China Perspective
2. Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger
3. Advanced Technologies and Wireless Telecommunications Enhance Care and Medical Training at the Ryder Trauma Center in Miami
4. Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products Neurodegenerative Diagnostics
5. Alfred Mann Foundation for Biomedical Engineering Launches New Web Site Designed to Help University Researchers Bring Biomedical Advances to Market
6. Delcath Adds University of Pittsburgh Medical Center to Phase III Trial
7. The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology
8. Starch Medical Launches New, Bioinert Surgical Hemostats
9. Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment
10. New Radiation-Blocking Medical Garments Introduced at RSNA Meeting in Chicago : Demron-M Technology Provides Total Protection in a Lightweight, Durable, Flexible Fabric
11. Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 2014   , ... Officer zu KLOX    ... Financial Officer bestellt    KLOX ist ... jüngst zugelassenen Behandlungssystems zur Wundheilung zu beginnen    , ... ist sehr erfreut, die folgenden personellen Veränderungen anzukündigen: ...
(Date:11/21/2014)... 20, 2014 Author Matthew J. Pallamary’s ... the Other Side” published as a tribute to ... the “Fiction: Short Story” category of the 2014 ... and CEO of USA Book News, said this year’s ... publishers, including Simon & Schuster, Penguin, John Wiley & ...
(Date:11/21/2014)... November 21, 2014 Why did Stephen ... Albert Einstein so instantly recognizable? Why have they become ... astronomer and author Hilton Ratcliffe seeks out the answers ... at all to do with science. In " Stephen ... , November 21, 2014), Ratcliffe puts it plainly: ...
(Date:11/21/2014)... YORK and SAN DIEGO , ... ), today announced that President and CEO Marc Hedrick , ... DATE:   Thursday, December 4, 2014 TIME: ... Click here or paste this URL into your ... recommended that investors pre-register to save time and receive event ...
Breaking Biology Technology:KLOX Technologies meldet Neubesetzung von Führungspositionen 2KLOX Technologies meldet Neubesetzung von Führungspositionen 3KLOX Technologies meldet Neubesetzung von Führungspositionen 4KLOX Technologies meldet Neubesetzung von Führungspositionen 5Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 2Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 3Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 4“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 2“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 3“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 4Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 2Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 3Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 4
... to ICD and CRT-D ... device ... BSX ) today announced a new clinical science initiative,ALTITUDE, which will ... the substantial LATITUDE data to,seek answers to common questions related to ...
... May 15 Human Genome Sciences,Inc. (Nasdaq: ... has joined the,Company as Vice President, Hepatology Franchise. ... Hematology, Genentech Corporation, will,report to Barry A. Labinger, ... http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO ), "Kevin McRaith brings ...
... QUEBEC CITY, May 15 /PRNewswire-FirstCall/ - AEterna Zentaris ... biopharmaceutical company focused on,endocrine therapy and oncology, today ... Officer, Dennis Turpin, CA, will present a,company overview ... Global,Healthcare Conference on Tuesday, May 20, 2008 at ...
Cached Biology Technology:Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data 2Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data 3Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data 4Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise 2Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise 3AEterna Zentaris to Present at Upcoming Rodman & Renshaw Global Healthcare Conference and AUA Annual Meeting 2
(Date:11/21/2014)... C-Labs LLC, a leading provider of remote ... today announced the appointment of John Traynor ... strategic advisor to the firm, Mr. Traynor will now ... based out of the C-Labs office in ... Muench , Chief Executive Officer. Photo - ...
(Date:11/18/2014)... , Nov. 18, 2014  The Secure ... Industry Association today jointly announce the formation of ... release of its Identity and Biometric Entry ... The Framework received official support from BORDERPOL, the ... to improve and provide expertise regarding border security, ...
(Date:11/18/2014)... Md. , Nov. 17, 2014 The Parenteral ... and U.S. regulatory agencies will speak and at least seven ... Metrics Conference at the Omni Shoreham Hotel in ... pleased once again to have significant support from the regulatory ... Europe in our effort to help ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
... Atlantic right whale's future looks grim if the current ... professor of oceanography Douglas Nowacek and a group of ... co-authored a paper titled "North Atlantic Right Whales in ... the journal Science. , In it, Nowacek and his ...
... the final step in the completion of new blood vessel ... Diego (UCSD) School of Medicine team in research that promises ... by cutting off the tumor blood supply. , The research ... at UCSD and a member of the Rebecca and John ...
... Scientists may have found a way to dramatically slow ... , That's the promising implication of an animal study ... at Birmingham (UAB) and the University of Florida (UF) ... the National Academy of Sciences. , The research team ...
Cached Biology News:FSU scientist warns North Atlantic right whale facing extinction 2Unexpected lock and key mechanism found for the assembly of tumor blood vessels 2Unexpected lock and key mechanism found for the assembly of tumor blood vessels 3Discoveries by UAB and Florida scientists may help transplanted organs survive longer 2
... carry-over contamination, which prevents false positive ... from previous PCR amplifications without degrading ... amplification ,Optimized for use with GeneAmp ... systems , The GeneAmp PCR Carry-over ...
... enzyme that catalyzes the conversion,of starch ... maltotriose and,dextrins. The level of a-amylase ... are of clinical importance,1-3 while plant ... industry.4, The EnzChek Amylase Assay Kit ...
... that catalyzes the hydrolysis of,starch to ... dextrins. The,level of a-amylase in various ... of,clinical significance in the diagnosis of ... and microbial a-amylases are,important enzymes for ...
Rat monoclonal [20d5] to NKG2A + C+ E ( Abpromise for all tested applications). Antigen: Tissue / cell preparation (Mouse): CHO transfected cells expressing the B6 allele of NKG2A. Entrez Gen...
Biology Products: